Alerts will be sent to your verified email
Verify Email
KIMIABL
|
Kimia Biosciences
|
Krebs Biochem.&Inds
|
Achyut Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
4.19 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-335.15 % | 37.05 % | 1.93 % |
|
5yr average Equity Multiplier
|
66.02 | -2.13 | 1.21 |
|
5yr Average Asset Turnover Ratio
|
1.14 | 0.3 | 0.29 |
|
5yr Avg Net Profit Margin
|
-0.67 % | -55.19 % | 7.92 % |
|
Price to Book
|
12.0 | 0.0 | 4.25 |
|
P/E
|
14.51 | 0.0 | 242.43 |
|
5yr Avg Cash Conversion Cycle
|
-33.97 Days | -1144.52 Days | 36.15 Days |
|
Inventory Days
|
101.63 Days | 102.59 Days | 38.82 Days |
|
Days Receivable
|
98.68 Days | 8.23 Days | 105.12 Days |
|
Days Payable
|
171.28 Days | 623.06 Days | 84.53 Days |
|
5yr Average Interest Coverage Ratio
|
0.78 | -4.97 | 272.88 |
|
5yr Avg ROCE
|
10.6 % | -23.43 % | 2.78 % |
|
5yr Avg Operating Profit Margin
|
3.89 % | -34.39 % | -2.63 % |
|
5 yr average Debt to Equity
|
29.85 | -1.88 | 0.0 |
|
5yr CAGR Net Profit
|
13.51 % | -0.84 % | 122.88 % |
|
5yr Average Return on Assets
|
-0.69 % | -16.47 % | 1.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.94 % | 72.74 % | 47.07 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -19.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kimia Biosciences
|
Krebs Biochem.&Inds
|
Achyut Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|